Filter By Unselect All

Sub Category Unselect

Country Unselect See All

China (1)

France (2)

India (2)

Italy (2)

Companies Unselect See All

Selected Filter(s): Reset All

  • Category
  • Reset
  • Sub Category
  • Reset
  • Country
  • Reset

Contact

Ultra & Nanofiltration

API & Drug Product Development >> API Development >> Overview

Zach has over 30 years of experience in multi-step syntheses involving complex reactions.We have dedicated R&D and analytical development teams on each site, and state-of-the art analytical equipment.

Contact

Containment Solution for Beta-Lactams

API & Drug Product Development >> API Development >> Overview

Dedicated laboratory and infrastructure addressing the needs of clients with highly potent synthetic molecules including containment solutions for beta-lactams.

Contact

Particle Design and Engineering

API & Drug Product Development >> API Development >> Overview

Delivering reliable and scalable crystallization processes through market leading capabilities and technologies in engineered API particle characterization.

Contact

Overview

API & Drug Product Development >> API Development >> Overview

Servier brings 60 years of experience in process development, intermediates, APIs and high-potency APIs. Our full cGMP / FDAapproved chemistry network includes R&D, production and supply chain expertise with full regulatory support. Servier CDMO’s teams are able to follow your projects from

Contact

CDMO Capabilities for APIs

API & Drug Product Development >> API Development >> Overview

An offer complying with Good Manufacturing Practices (GMP), closely monitored by the Quality Insurance and Regulatory Affairs services: Laboratory, Kilolab, Pilot, industrial production and preparatory chromatography services.

Contact

Teratogenic Compounds

API & Drug Product Development >> API Development >> Overview

Dedicated laboratory and infrastructure addressing the needs of clients with highly potent synthetic molecules including containment solutions for beta-lactams.

Contact

Asymmetric Amino Acids Transformations by Diazotation

API & Drug Product Development >> API Development >> Overview

R&D center is located in High-tech park of Shanghai with area about 1,000 square meters. It is equipped with chemical synthesis room, formulation room and advanced instrument room. What’s more, there are 5 professionals focusing on new drug development.

Contact

Development of High-Value/Low-Volume Niche-Complex APIs

API & Drug Product Development >> API Development >> Overview

Sequent has invested in facilities with an objective of creating an integrated, flexible unit capable of manufacturing several niche & complex APIs. The manufacturing facalities are capable of meeting the growing demand of our key products in the USFDA and WHO regulated markets.

Contact

Chiral Synthesis

API & Drug Product Development >> API Development >> Overview

R&D center is located in High-tech park of Shanghai with area about 1,000 square meters. It is equipped with chemical synthesis room, formulation room and advanced instrument room. What’s more, there are 5 professionals focusing on new drug development.

Contact

Development of APIs

API & Drug Product Development >> API Development >> Overview

Drug’On Pharma Switzerland was the last company to be set up in the Orofino Pharmaceuticals Group. The Group bought out the ex Knoll and Abbott manufacturing site in Liestal,Switzerland. The chemical manufacturing site produces active pharmaceuticals ingredients (API) and intermediates.

PharmaCompass >>